a b s t r a c t
Adverse neurodevelopmental outcomes are linked to perinatal production of inflammatory mediators, including interleukin 6 (IL-6). While a pivotal role for maternal elevation in IL-6 has been established in determining neurobehavioral outcomes in the offspring and considered the primary target mediating the fetal inflammatory response, questions remain as to the specific actions of IL-6 on the developing brain. CD-1 male mice received a subdural injection of the bioactive fusion protein, hyper IL-6 (HIL-6) on postnatal-day (PND)4 and assessed from preweaning until adulthood. Immunohistochemical evaluation of astrocytes and microglia and mRNA levels for pro-inflammatory cytokines and host response genes indicated no evidence of an acute neuroinflammatory injury response. HIL-6 accelerated motor development and increased reactivity to stimulation and number of entries in a light/dark chamber, decreased ability to learn to withhold a response in passive avoidance, and effected deficits in social novelty behavior. No changes were observed in motor activity, pre-pulse startle inhibition, or learning and memory in the Morris water maze or radial arm maze, as have been reported for models of more severe developmental neuroinflammation. In young animals, mRNA levels for MBP and PLP/DM20 decreased and less complexity of MBP processes in the cortex was evident by immunohistochemistry. The nonhydroxy cerebroside fraction of cerebral lipids was increased. These results provide evidence for selective effects of IL-6 signaling, particularly trans-signaling, in the developing brain in the absence of a general neuroinflammatory response. These data contribute to our further understanding of the multiple aspects of IL-6 signaling in the developing brain.
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Introduction
Early inflammatory responses in the fetus and neonate may underlie a diverse range of long-lasting effects on the nervous system (Hagberg and Mallard, 2005) . The link between maternal infection and adverse effects in the offspring is thought related to an increased availability of maternal inflammatory factors and induction of a fetal inflammatory response (Cai et al., 2003; Ashdown et al., 2006; Beloosesky et al., 2006; Dammann and O'Shea, 2008) . This involves increased production of interleukin (IL)-1, -6, -8, and tumor necrosis factor alpha (TNFa) in chorionic membranes, amniotic fluid, and fetal blood (Fidel et al., 1994; Goepfert et al., 2004) . Animal models support neuroinflammation with maternal (Boksa, 2010; Gayle et al., 2004; Meyer et al., 2009) or post-natal inflammatory challenge (Cai et al., 2003; Pang et al., 2006) being associated with adverse effects on brain development, myelination (Paintlia et al., 2004; Pang et al., 2003; Loron et al., 2011), and behavior (Shi et al., 2003; Zuckerman et al., 2003; Bilbo et al., 2006; Meyer et al., 2006; Ozawa et al., 2006) . In each model, a diverse array of inflammatory responses occurs in the dam or pup. Efforts to tease out critical causative inflammatory factors identified maternal-derived IL-6 as a pivotal factor. In rodent lipopolysaccharide (LPS) models of gestational infection, maternal derived IL-6 contributes to deficits in pre-pulse startle inhibition, latent inhibition and social interactions (Samuelsson et al., 2006; Smith et al., 2007) . The nature of the effect shifts with age of exposure (Meyer et al., 2006) . Exposure of the postnatal brain to recombinant IL-6 showed did not recapitulate the LPS effects however, the co-administration of an IL-6 neutralizing antibody was effective in blocking the LPS-induced effects (Pang et al., 2006) . These findings suggested that, while pivotal, the contribution of IL-6 in developmental neuroinflammation might be related
